Cervomed to host virtual kol event on neflamapimod for dementia with lewy bodies on july 23, 2024

Boston, july 11, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that it will host a virtual key opinion leader (kol) event on tuesday, july 23, 2024 at 10:00 am et.
CRVO Ratings Summary
CRVO Quant Ranking